Literature DB >> 7704951

A one-step sandwich enzyme immunoassay for inactive precursor and complexed forms of human matrix metalloproteinase 9 (92 kDa gelatinase/type IV collagenase, gelatinase B) using monoclonal antibodies.

N Fujimoto1, N Hosokawa, K Iwata, T Shinya, Y Okada, T Hayakawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7704951     DOI： 10.1016/0009-8981(94)90256-9

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN： 0009-8981            Impact factor:   3.786


× No keyword cloud information.
  17 in total

1.  Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis.

Authors:  Y Yoshihara; H Nakamura; K Obata; H Yamada; T Hayakawa; K Fujikawa; Y Okada
Journal:  Ann Rheum Dis       Date:  2000-06       Impact factor: 19.103

2.  Secretion of matrix metalloproteinase-2 (72 kD gelatinase/type IV collagenase = gelatinase A) by malignant human glioma cell lines: implications for the growth and cellular invasion of the extracellular matrix.

Authors:  T Nakagawa; T Kubota; M Kabuto; N Fujimoto; Y Okada
Journal:  J Neurooncol       Date:  1996-04       Impact factor: 4.130

3.  Serum matrix metalloproteinase-3 levels correlate with disease activity in relapsing-remitting multiple sclerosis.

Authors:  T Kanesaka; M Mori; T Hattori; T Oki; S Kuwabara
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

4.  Differences between scirrhous and non-scirrhous human gastric carcinomas from the aspect of proMMP-2 activation regulated by TIMP-3.

Authors:  Takeyoshi Yokoyama; Hiroyuki Nakamura; Yoshihide Otani; Tetsuro Kubota; Noboru Fujimoto; Motoharu Seiki; Masaki Kitajima; Yasunori Okada
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

5.  Increased matrix metalloproteinases as possible cause of osseoarticular tissue destruction in long-term haemodialysis and beta 2-microglobulin amyloidosis.

Authors:  K Ohashi; R Kawai; M Hara; Y Okada; S Tachibana; Y Ogura
Journal:  Virchows Arch       Date:  1996-04       Impact factor: 4.064

6.  Levels of urinary matrix metalloproteinase-9 (MMP-9) and renal injuries in patients with type 2 diabetic nephropathy.

Authors:  Kyoichi Tashiro; Ichiro Koyanagi; Ikko Ohara; Takamichi Ito; Akemi Saitoh; Satoshi Horikoshi; Yasuhiko Tomino
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

7.  Rapid, simple, and reliable method for the diagnosis of CAPD peritonitis using the new MMP-9 test kit.

Authors:  Yuuki Ro; Chieko Hamada; Hiroaki Io; Kayo Hayashi; Ichiro Hirahara; Yasuhiko Tomino
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

8.  Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion.

Authors:  Y Ueda; K Imai; H Tsuchiya; N Fujimoto; I Nakanishi; S Katsuda; M Seiki; Y Okada
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

9.  Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome.

Authors:  Giuseppe Derosa; Angela D'Angelo; Filippo Scalise; Maria A Avanzini; Carmine Tinelli; Emmanouil Peros; Elena Fogari; Arrigo F G Cicero
Journal:  Heart Vessels       Date:  2007-11-26       Impact factor: 2.037

10.  Effect of Smoking on Metalloproteinases (MMPs) Activity in Patients with Acute Myocardial Infarction (AMI).

Authors:  Sreekanth K Sivaraman; Geevar Zachariah; Pt Annamala
Journal:  J Clin Diagn Res       Date:  2014-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.